OCUMENSION THERAPEUTICS revenue for the last year amounted to 271.04 M HKD, the most of which — 272.24 M HKD — came from its highest performing source at the moment, Ophthalmic Pharmaceutical Platform, the year earlier bringing 184.85 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought OCUMENSION THERAPEUTICS 272.24 M HKD, and the year before that — 184.85 M HKD.